Clinical significance of fetal nuchal translucency during early pregnancy.
- Author:
Jae Yoon SHIM
1
;
Jong Yun HWANG
;
Sun Kwon KIM
;
Bon Sang KOO
;
Hye Sung WON
;
Pil Ryang LEE
;
Ahm KIM
Author Information
1. Department of Obstetrics and Gynecology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea. akim@amc.seoul.kr
- Publication Type:Original Article
- Keywords:
Early pregnancy;
Nuchal translucency;
Chromosomal abnormality;
Major cardiac defect
- MeSH:
Abnormal Karyotype;
Autopsy;
Chromosome Aberrations;
Crown-Rump Length;
Echocardiography;
Female;
Fetus;
Gestational Age;
Humans;
Infant, Newborn;
Karyotype;
Karyotyping;
Mass Screening;
Nuchal Translucency Measurement*;
Physical Examination;
Pregnancy Outcome;
Pregnancy*;
Prevalence;
Ultrasonography
- From:Korean Journal of Obstetrics and Gynecology
2005;48(4):875-883
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: To examine the significance of fetal nuchal translucency during early pregnancy in detection of chromosomal abnormality and major cardiac defect METHODS: Between Jul 1998 and Jul 2002, ultrasound examination was performed in 1,253 unselected singleton pregnancies with a live fetus and fetal crown rump length of 24-88 mm. The fetal nuchal translucency thickness was measured successfully in all cases. We reviewed the pregnancy outcome about two parameters. Chromosomal abnormality was confirmed by antenatal karyotyping and newborn's feature suggestive of a chromosomal defect. Major cardiac defect was confirmed by newborn physical examination, targeted ultrasonography, neonatal echocardiography and autopsy. RESULTS: (1) Fetal nuchal translucency thickness increased significantly with crown-rump length. (2) Nuchal translucency was greater than 3 mm in 12 pregnancies with abnormal karyotypes, giving a detection rate of 75.0% with a false positive rate of 4.0%. With a cutoff of 2.5 mm, a detection rate of abnormal karyotype was 81.3% with a false positive rate of 8.3%. And with a gestational age specific cutoff, 95 percentile, a detection rate of abnormal karyotype was 75%, with a false positive rate of 6.4%. (3) With normal karyotype, the overall prevalence of major cardiac defects in this study population was 5/1,000 pregnancies (5/1,054). This prevalence increased from 48/1,000 (4/83) using 2.5 mm cutoff to 105/1,000 (4/38) using 3 mm cutoff. The detection rate for major cardiac defect of nuchal translucency above 3 mm is 80.0% with a false positive rate of 3.2%. CONCLUSION: Increased nuchal translucency is by far an important and efficient marker for screening of chromosomal defects and effective screening method for major cardiac defects.
